YAMAGATA UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1878-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.yamagata-u.ac.jp/
Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma
Phase 3
- Conditions
- Metastatic Renal Cell Carcinoma
- Interventions
- Drug: Sorafenib-sunitinibDrug: Sunitinib-sorafenib
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- Yamagata University
- Target Recruit Count
- 120
- Registration Number
- NCT01481870
- Locations
- 🇯🇵
Yamagata University Faculty of Medicine, Yamagata, Japan
© Copyright 2025. All Rights Reserved by MedPath